BioAge Labs develops drug candidates for cardiometabolic diseases, using human aging biology to identify its drug targets. It last closed at $4.28 on Nov 20, down 9.13% on the day. The next earnings report for BIOA is expected around Tue, Mar 23, 2027. For the quarter ended Sep 2026, BIOA reported EPS of -$0.73 on revenue of $298,000, with revenue down 85.5% from a year ago. Over its last 8 reports the stock moved an average of 3.6% the session after earnings. Over the last 12 months BIOA insiders bought $0 of stock on the open market and sold $7.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is BIOA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BIOA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BIOAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BIOA · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 28% below its 20 day and 44% below its 50 day average. It is 244% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the 52 week low at $4.24, and the nearest resistance the Pivot at $4.44.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 10.5%/day
Key levels
$25.9552 week high+506.3%
$14.74200 day average+244.4%
$10.71100 day average+150.2%
$6.1850 day average+44.4%
$5.70Swing high (Oct 21)+33.2%
$5.4720 day average+27.8%
$4.64Pivot R1+8.4%
$4.44Pivot+3.7%
$4.28Last close
$4.2452 week low−0.9%
$4.08Pivot S1−4.7%
Indicators
RSI (14)
26.89
Oversold below 30
Oversold
MACD
-0.43
Below its signal line
Bearish
Stochastic
5.3
Near the bottom of its range
Oversold
ADX (14)
22.7
Weak trend
Williams %R
-97.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-190.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−19.9%
Change over 10 sessions
Bearish
ATR (14)
$0.45
Typical daily range, 10.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityHigh, 46.6%/day
Key levels
$25.9552 week high+506.3%
$14.74200 day average+244.4%
$10.71100 day average+150.2%
$6.1850 day average+44.4%
$5.70Swing high (Oct 21)+33.2%
$5.4720 day average+27.8%
$4.64Pivot R1+8.4%
$4.44Pivot+3.7%
$4.28Last close
$4.2452 week low−0.9%
$4.08Pivot S1−4.7%
Indicators
RSI (14)
31.23
Weak, oversold below 30
Neutral
MACD
-3.06
Below its signal line
Bearish
Stochastic
6.2
Near the bottom of its range
Oversold
ADX (14)
41.1
Strong downtrend
Williams %R
-99.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-83.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−49.6%
Change over 10 sessions
Bearish
ATR (14)
$2.00
Typical daily range, 46.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for BIOA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BIOA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BIOAHow many large options trades hit BIOA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BIOA in the last 90 days.
From SEC Form 4 filings by BIOA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BIOA is in one of them and how their past BIOA trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About BioAge Labs
BioAge Labs is a biopharmaceutical company based in Emeryville, California, that develops drug candidates for chronic cardiometabolic diseases such as heart disease, diabetes and obesity. Its approach uses human datasets from long-term biobanked samples and health records to find biological pathways linked to aging. Its lead candidate, BGE-102, is an oral NLRP3 inhibitor being studied for cardiovascular risk and diabetic macular edema. The company is also developing apelin receptor agonists for obesity and works with Eli Lilly and Novartis on earlier stage programs.